APRIL 2023LIFE SCIENCES REVIEW1EDITIONCANCER IMMUNOTHERAPYLIFESCIENCESREVIEW.COMAPRIL - 03 - 2023EUROPE SPECIALISSN 2831-8331CELLEX CELL PROFESSIONALSBRINGING INNOVATIVE CONCEPTS TO THE CLINICCarla Kreissig, CEO
Page 2 >